GENA-OT is a technology demonstrationCubeSat mission developed by the European Space Agency (ESA) and OroraTech. In-Orbit Demonstration/Validation (IOD/IOV) is the practice of testing innovative technologies by flying them in Earth orbit before they can be used on operational space missions. GENA-OT is an In-Orbit Demonstration (IOD) of a generic, flexible IOD/IOV satellite platform. GENA-OT launched in November 2025 on the Falcon9 flight Transporter-15 and began its orbital operations.
Payload
The satellite payload space has been acquired by the University of the Bundeswehr Munich. As part of the research program SeRANIS, the research center SPACE of the university developed and delivered most of the payloads for GENA-OT. One of the other payloads is SpaceRadMon, an instrument for monitoring effects of space radiation on electronic component, developed by ESA and CERN. Another payload is the Icarus receiver of the Max Planck Society's ICARUS Initiative for global wildlife tracking from space.
Launches are separated by dots ( • ), payloads by commas ( , ), multiple names for the same satellite by slashes ( / ). Crewed flights are underlined. Launch failures are marked with the † sign. Payloads deployed from other spacecraft are (enclosed in parentheses).